HALEOSLABS NSE filing

Haleos Labs Shareholders Approve Director Reappointment & RPTs; Reject Remuneration

The RealCase readMedium impact Neutral

Haleos Labs shareholders approved the reappointment of Mrs. Sudeepthi Gopineedi as Whole-time Director and material related party transactions for 2026-27. However, the resolution for managerial remuneration to Executive Directors was not approved. The postal ballot voting concluded on August 28, 2026.

Why it matters

The approval of director reappointment and related party transactions is significant for ongoing operations. However, the rejection of managerial remuneration could impact executive compensation strategies and potentially lead to further discussions or adjustments, thus having a medium impact.

The market read

While key appointments and transactions were approved, the rejection of the managerial remuneration resolution introduces a neutral sentiment as it indicates shareholder dissent on a specific executive compensation matter.

Haleos Labs Limited (formerly SMS Lifesciences India Limited) announced the results of its postal ballot process, conducted via e-voting, which concluded on August 28, 2026. Shareholders approved three out of four resolutions. Specifically, the reappointment of Mrs. Sudeepthi Gopineedi as Whole-time Director for a further five-year period was passed as a Special Resolution. Additionally, Ordinary Resolutions for the approval of Material Related Party Transactions for the company and its Material Subsidiary for the year 2026-27 were also approved.

However, a Special Resolution seeking approval for the payment of managerial remuneration to Executive Directors did not receive the requisite majority and was consequently not approved. The company confirmed that resolutions 1, 3, and 4 are deemed passed as of August 28, 2026.

The postal ballot notice was dated May 29, 2026, and the e-voting period ran from July 30, 2026, to August 28, 2026. The results, along with the Scrutinizer's Report, have been disclosed as per SEBI regulations and will be uploaded on the company's website.

Primary source

A plain-language summary of a public exchange filing by HALEOS LABS LIMITED. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only